Lee Ainslie - Maverick Capital
Holding/activity history for Rocket Pharmaceuticals Inc. (RCKT)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q4 | 4,034,068 | 2.49 | Reduce 28.35% | 0.99 | $29.97 |
| 2023 Q3 | 5,629,970 | 2.70 | Add 28.54% | 0.60 | $20.49 |
| 2023 Q2 | 4,379,970 | 1.86 | Reduce 0.63% | 0.01 | $19.87 |
| 2023 Q1 | 4,407,623 | 1.94 | Add 29.80% | 0.45 | $17.13 |
| 2022 Q4 | 3,395,818 | 1.62 | Add 34.10% | 0.41 | $19.57 |
| 2022 Q3 | 2,532,366 | 0.91 | $15.96 | ||
| 2022 Q2 | 2,532,366 | 0.87 | Add 18.71% | 0.14 | $13.76 |
| 2022 Q1 | 2,133,166 | 0.61 | Add 12.57% | 0.07 | $15.86 |
| 2021 Q4 | 1,894,966 | 0.50 | Add 14.15% | 0.06 | $21.83 |
| 2021 Q3 | 1,660,116 | 0.55 | Add 854.71% | 0.49 | $29.89 |
| 2021 Q2 | 173,887 | 0.07 | Buy | 0.07 | $44.29 |